Latest Articles

Subject

Research Article
Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3A Systematic Review and Meta-analysis
Dalia Rotstein, Jacqueline M. Solomon, Maria Pia Sormani, et al.

October 12, 2022
Research Article
Area Postrema Syndrome in Autoimmune Glial Fibrillary Acidic Protein AstrocytopathyA Case Series and Literature Review
Bo Deng, Jingguo Wang, Hai Yu, et al.

September 26, 2022
Research Article
Pachymeningitis in Biopsy-Proven SarcoidosisClinical Course, Radiographic Findings, Response to Treatment, and Long-term Outcomes
Pressley A. Chakales, Max C. Herman, Ling Chen Chien, et al.

September 26, 2022
Research Article
CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple Sclerosis
Antoine Philippe Fournier, Stephanie Zandee, Marc Charabati, et al.

September 09, 2022
Correction
MRI Characteristics of Autoimmune Encephalitis With Autoantibodies to GABAA Receptor: A Case Series
September 07, 2022
Review
Microglia as Central Protagonists in the Chronic Stress Response
Eva Schramm, Ari Waisman

September 07, 2022
Review
Toward Precision Phenotyping of Multiple Sclerosis
David Pitt, Chih Hung Lo, Susan A. Gauthier, et al.

August 30, 2022
Research Article
Updated Results of the COVID-19 in MS Global Data Sharing InitiativeAnti-CD20 and Other Risk Factors Associated With COVID-19 Severity
Steve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, et al.

August 29, 2022
Research Article
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis
Jason R. Thonhoff, James D. Berry, Eric A. Macklin, et al.

August 29, 2022
Correction
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod
August 26, 2022

Pages